Antibody titer against malondialdehyde (MDA)-modified low-density lipoprotein (LDL) has been found to be associated with atherosclerosis, but it has not been established whether it would detect subjects with coronary artery disease (CAD)...
Keywords: antibodies, coronary artery disease, high-density lipoprotein cholesterol, malondialdehyde-modified low-density lipoprotein, receiver-operating characteristic analysis
04/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter